Newer Avenues for the Treatment of Leptomeningeal Carcinomatosis

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 38-44

Bentham Science Publishers

Access to resources Recommend Favorite

Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical Setting: Implications of the Barriers Between Blood and Brain

By de Lange E.C.M.   Danhof M.  

Clinical Pharmacokinetics, Vol. 41, Iss. 10, 2002-01 ,pp. : 691-703

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Cephalosporins in Cerebrospinal Fluid

By Lutsar I.  

Clinical Pharmacokinetics, Vol. 39, Iss. 5, 2000-11 ,pp. : 335-343

Adis International

Access to resources Recommend Favorite

Metabolic Profiling in Multiple Sclerosis and Other Disorders by Quantitative Analysis of Cerebrospinal Fluid Using Nuclear Magnetic Resonance Spectroscopy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 7, 2011-07 ,pp. : 1016-1025

Bentham Science Publishers

Access to resources Recommend Favorite

Pathological analysis of children with childhood central nervous system infection based on changes in chemokines and interleukin‐17 family cytokines in cerebrospinal fluid

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite